Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: A multicentre, randomised, dose-escalation phase 1 study

Jean Pierre J. Issa, Gail Roboz, David Rizzieri, Elias Jabbour, Wendy Stock, Casey O'Connell, Karen Yee, Raoul Tibes, Elizabeth A. Griffiths, Katherine Walsh, Naval Daver, Woonbok Chung, Sue Naim, Pietro Taverna, Aram Oganesian, Yong Hao, James N. Lowder, Mohammad Azab, Hagop Kantarjian

Research output: Contribution to journal › Article › peer-review

192 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: A multicentre, randomised, dose-escalation phase 1 study'. Together they form a unique fingerprint.

Medicine & Life Sciences